Provenance
Developed by SPS, the British Association of Sexual Health and HIV (BASHH), the British Association of HIV (BHIVA) and the support of specialist stakeholders working within clinical practice for sexual health services.
Template versions available
Version 3.0 of this PGD template, valid from April 2026, has been published to allow organisations to undertake local governance processes in a timely manner.
Version 2.1 of this PGD template remains currently valid and will be removed from this page on its expiry (31st March 2026).
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice.
More sexual health PGD templates
- Doxycycline post exposure prophylaxis (doxyPEP)
- Podophyllotoxin (topical) for external anogenital warts
- Imiquimod 5% w/w cream for anogenital warts
- Aciclovir (oral) for genital HSV infection
- Fluconazole 150mg capsules for candidiasis
- Clotrimazole pessaries for candidiasis
- Clotrimazole cream for candidiasis and candidal balanoposthitis
- Ceftriaxone intramuscular injection for Neisseria gonorrhoeae
- Metronidazole (oral) for use within sexual health services
- Azithromycin (oral) for use within sexual health services
- Emtricitabine/tenofovir and raltegravir tablets for HIV PEP
- Emtricitabine and tenofovir disoproxil tablets as PrEP
All PGD templates
National PGD templates
National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
Update history
- Version 3.0 PGD template added
- Version 2.1 published to reflect SPC changes
- Title, URL and summary amended.
- Version 1 removed as expiring end March '23
- Version 2.0 PGD template added
- Published